首页> 外国专利> EXPRESSION OF ENDOGENOUS GENES BY NON-HOMOLOGOUS RECOMBINATION OF A VECTOR CONSTRUCT WITH CELLULAR DNA

EXPRESSION OF ENDOGENOUS GENES BY NON-HOMOLOGOUS RECOMBINATION OF A VECTOR CONSTRUCT WITH CELLULAR DNA

机译:向量结构与细胞DNA的非同源重组表达内源基因

摘要

The present invention relates generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also relates generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. In another embodiment, the expression of the endogenous gene may be further increased by co-integration of one or more amplifiable markers, and selecting for increased copies of the one or more amplifiable markers located on the integrated vector. The invention also provides methods for the identification and expression of genes undiscoverable by current methods since no target sequence is necessary for integration. The invention also provides methods for isolation of nucleic acid molecules (particularly cDNA molecules) encoding transmembrane proteins, and for isolation of cells expressing such transmembrane proteins which may be heterologous transmembrane proteins. The invention also relates to isolated genes, gene products, nucleic acid molecules, and compositions comprising such genes, gene products and nucleic acid molecules, that may be used in a variety of therapeutic and diagnostic applications. Thus, by the present invention, endogenous genes, including those associated with human disease and development, may be activated and isolated without prior knowledge of the sequence, structure, function, or expression profile of the genes.
机译:本发明总体上涉及通过原位重组方法激活基因表达或引起基因的过表达。本发明还总体上涉及用于以高于细胞中通常发现的水平的水平在细胞中表达内源基因的方法。在本发明的一个实施方案中,内源基因的表达在整合到细胞中之后通过非同源或非法重组重组激活该基因表达的调控序列而被激活或增加。在另一个实施方案中,可以通过共整合一个或多个可扩增标记,并选择位于整合载体上的一个或多个可扩增标记的增加拷贝来进一步增加内源基因的表达。本发明还提供了鉴定和表达无法通过当前方法发现的基因的方法,因为整合不需要靶序列。本发明还提供了用于分离编码跨膜蛋白的核酸分子(特别是cDNA分子),以及用于分离表达可以是异源跨膜蛋白的这种跨膜蛋白的细胞的方法。本发明还涉及分离的基因,基因产物,核酸分子以及包含此类基因,基因产物和核酸分子的组合物,其可以用于多种治疗和诊断应用中。因此,通过本发明,内源基因,包括与人类疾病和发育相关的内源基因,可以被激活和分离,而无需事先知道基因的序列,结构,功能或表达特征。

著录项

  • 公开/公告号EP1017803B1

    专利类型

  • 公开/公告日2010-06-16

    原文格式PDF

  • 申请/专利权人 ABT HOLDING COMPANY;

    申请/专利号EP19980949508

  • 发明设计人 HARRINGTON JOHN J.;

    申请日1998-09-25

  • 分类号C12N15/11;C12N15/63;C12N15/85;C12N15/86;C12N15/00;C12P21/00;A61K48/00;

  • 国家 EP

  • 入库时间 2022-08-21 18:40:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号